Increased Lead Exposure May Raise Kidney Cancer Risk

Share this article:

Higher blood lead levels are associated with an elevated risk of renal cell carcinoma (RCC), according to a study.

The study, led by Robin Taylor Wilson, PhD, of Pennsylvania State University College of Medicine in Hershey, included 154 individuals with a new diagnosis of RCC and 308 matched controls. The subjects were male Finnish smokers participating in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study. The mean follow-up time was 12.1 years for cases and 18.1 years for controls.

Compared with subjects in the first quartile of blood lead level (below 2.50 µg/dL), those in the fourth quartile (4.66 µg/dL and higher) had a twofold increased risk of RCC after adjusting for confounders, the researchers reported in Cancer Epidemiology, Biomarkers & Prevention (published online ahead of print).

Higher total serum calcium was associated with a significantly reduced risk of RCC. Compared with subjects in the first quartile of serum calcium (below 9.50 mg/dL), those in the fourth quartile (10.30 mg/dL or higher) had a 70% decreased risk.

In addition, the study showed that among cases alone, lower baseline serum calcium was significantly associated with a shorter time to RCC diagnosis after study enrollment, after adjusting for other RCC risk factors, such as age at randomization, pack-years of smoking, body mass index, and systolic blood pressure.

Mean total serum calcium levels were 9.5, 9.7, 9.8, and 9.9 mg/dL in those diagnosed from 5.0-8.9, 9.0-11.7, 11.8-15.1, and 15.2-20.9 years after study enrollment, respectively. The researchers observed a similar but nonsignificant trend with serum 25-hydroxyvitamin D levels.

Share this article:
You must be a registered member of RUN to post a comment.
close

Next Article in Kidney Cancer

More in Kidney Cancer

Statins Reduce Kidney Cancer Progression

Statins Reduce Kidney Cancer Progression

Reduced risk of progression of localized renal cell carcinoma observed in patients on statins.

Renal Mass Biopsy Seldom Used Pre-RCC Surgery

Renal Mass Biopsy Seldom Used Pre-RCC Surgery

Only 17% and 20% of patients undergoing radical or partial nephrectomy, respectively, had a renal mass biopsy in advance of surgery.

Percutaneous Biopsy Accurately Diagnoses Urothelial Carcinoma

Percutaneous Biopsy Accurately Diagnoses Urothelial Carcinoma

Technique provides a tissue diagnosis in 88% of cases, according to a study.